Grapefruit component interacting with rat and human P450 CYP3A: Possible involvement of non-flavonoid components in drug interaction

被引:0
|
作者
Fukuda, K [1 ]
Ohta, T [1 ]
Yamazoe, Y [1 ]
机构
[1] TOHOKU UNIV, FAC PHARMACEUT SCI, DIV PHARMACOGNOSY, AOBA KU, SENDAI, MIYAGI 980, JAPAN
关键词
grapefruit juice; cytochrome P450; flavonoid; CYP3A4; human liver; drug interaction; HUMAN-LIVER-MICROSOMES; HEPATIC CYTOCHROME-P-450 ISOZYMES; CITRUS JUICES; METABOLISM; INHIBITION; FELODIPINE; NARINGENIN; PHARMACOKINETICS; CYCLOSPORINE; NIFEDIPINE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Active components in grapefruit juice, which modulate a cytochrome P450 (CYP3A) activity, were investigated. CYP3A-catalyzed 6 beta-hydroxylation of testosterone in livers of rat and human was inhibited by the addition of an ethyl acetate-extract of grapefruit juice. Several components of grapefruit juice, including naringin, naringenin, limonin and obacunone, also showed inhibitory effects in human liver microsomes. However, the amounts of these components in grapefruit juice are too low to account for the inhibition by the ethyl acetate-extracts. Analyses with HPLC indicate the existence of inhibitory components in the extract, which are distinct from these known compounds and are specific to grapefruit juice. These results suggest that hydrophobic components other than flavonoids, probably coumarin derivatives, are responsible for the inhibitory effect of grapefruit juice.
引用
收藏
页码:560 / 564
页数:5
相关论文
共 20 条
  • [1] Metabolite complex formation of orphenadrine with cytochrome P450 - Involvement of CYP2C11 and CYP3A isozymes
    Roos, PH
    Mahnke, A
    BIOCHEMICAL PHARMACOLOGY, 1996, 52 (01) : 73 - 84
  • [2] Differential Expression of Human Cytochrome P450 Enzymes from the CYP3A Subfamily in the Brains of Alcoholic Subjects and Drug-Free Controls
    Depaz, Iris M. Booth
    Toselli, Francesca
    Wilce, Peter A.
    Gillam, Elizabeth M. J.
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (06) : 1187 - 1194
  • [3] Influence of Amlodipine Enantiomers on Human Microsomal Cytochromes P450: Stereoselective Time-Dependent Inhibition of CYP3A Enzyme Activity
    Krasulova, Kristyna
    Holas, Ondrej
    Anzenbacher, Pavel
    MOLECULES, 2017, 22 (11):
  • [4] A non-destructive BFCOD assay for in vivo measurement of cytochrome P450 3A (CYP3A) enzyme activity in fish embryos and larvae
    Oziolor, Elias M.
    Carey, Alexis N.
    Matson, Cole W.
    ECOTOXICOLOGY, 2017, 26 (06) : 809 - 819
  • [5] Interaction between 3,4-dichlorophenyl-propenoyl-sec.-butylamine (3,4-DCPB), an antiepileptic drug, and cytochrome P450 in rat liver microsomes and recombinant human enzymes in vitro
    Cheng, Hai-Xu
    Lu, Ying-Yuan
    Wang, Xin
    Ren, Hong
    Li, Qiang
    Wang, Shu-Mei
    Ding, Yu
    Lou, Ya-Qing
    Zhang, Guo-Liang
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 123 : 241 - 248
  • [6] Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4
    Danek, Przemyslaw J.
    Basinska-Ziobron, Agnieszka
    Wojcikowski, Jacek
    Daniel, Wladyslawa A.
    PHARMACOLOGICAL REPORTS, 2021, 73 (01) : 303 - 308
  • [7] Identification of polymorphisms in the 3′-untranslated region of the human pregnane X receptor (PXR) gene associated with variability in cytochrome P450 3A (CYP3A) metabolism
    Oleson, L.
    von Moltke, L. L.
    Greenblatt, D. J.
    Court, M. H.
    XENOBIOTICA, 2010, 40 (02) : 146 - 162
  • [8] Metabolic Activities Catalyzed by Human Cytochrome P450 (CYP) 2D6 and CYP3A Subfamily Members and Effect of Various Compounds, Including Endogenous Steroid Hormones, on These Activities
    Niwa, Toshiro
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2024, 144 (02): : 197 - 202
  • [9] Quantitative Prediction of Human Pregnane X Receptor and Cytochrome P450 3A4 Mediated Drug-Drug Interaction in a Novel Multiple Humanized Mouse Line
    Hasegawa, Maki
    Kapelyukh, Yury
    Tahara, Harunobu
    Seibler, Jost
    Rode, Anja
    Krueger, Sylvia
    Lee, Dongtao N.
    Wolf, C. Roland
    Scheer, Nico
    MOLECULAR PHARMACOLOGY, 2011, 80 (03) : 518 - 528
  • [10] Interaction of luteolin, naringenin, and their sulfate and glucuronide conjugates with human serum albumin, cytochrome P450 (CYP2C9, CYP2C19, and CYP3A4) enzymes and organic anion transporting polypeptide (OATP1B1 and OATP2B1) transporters
    Kaci, Hana
    Bodnarova, Slavka
    Fliszar-Nyul, Eszter
    Lemli, Beata
    Pelantova, Helena
    Valentova, Katerina
    Bakos, Eva
    Ozvegy-Laczka, Csilla
    Poor, Miklos
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 157